Xtant Medical 

$0.4081
20
-$0.01-2.81% Monday 20:00
+$0.00+0%Monday 20:00After hours

Statistics

Day High
0.4101
Day Low
0.41
52W High
0.95
52W Low
0.39
Volume
293
Avg. Volume
-
Mkt Cap
57.24M
P/E Ratio
41.99
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.09
0.03
0.15
0.28
Expected EPS
-0.02
Actual EPS
N/A

Financials

3.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
133.93MRevenue
4.97MNet Income

Analyst Ratings

1.00Average Price Target
The highest estimate is 1.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XTNT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.
Show more...
CEO
Mr. Sean E. Browne
Employees
151
Country
United States
ISIN
US98420P3082

Listings

0 Comments

Share your thoughts

FAQ

What is Xtant Medical stock price today?
The current price of XTNT is $0.41 USD — it has decreased by -2.81% in the past 24 hours. Watch Xtant Medical stock price performance more closely on the chart.
What is Xtant Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Xtant Medical stocks are traded under the ticker XTNT.
Is Xtant Medical stock price growing?
XTNT stock has fallen by -2.72% compared to the previous week, the month change is a -8.29% fall, over the last year Xtant Medical has showed a -36.57% decrease.
What is Xtant Medical market cap?
Today Xtant Medical has the market capitalization of 57.24M
When is the next Xtant Medical earnings date?
Xtant Medical is going to release the next earnings report on July 30, 2026.
What were Xtant Medical earnings last quarter?
XTNT earnings for the last quarter are -0.02 USD per share, whereas the estimation was -0.02 USD resulting in a -33.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xtant Medical revenue for the last year?
Xtant Medical revenue for the last year amounts to 133.93M USD.
What is Xtant Medical net income for the last year?
XTNT net income for the last year is 4.97M USD.
How many employees does Xtant Medical have?
As of July 14, 2026, the company has 151 employees.
In which sector is Xtant Medical located?
Xtant Medical operates in the Health & Wellness sector.
When did Xtant Medical complete a stock split?
The last stock split for Xtant Medical was on February 14, 2018 with a ratio of 1:12.
Where is Xtant Medical headquartered?
Xtant Medical is headquartered in Belgrade, United States.